UNSPSC 51203202: Mycophenolate mofetil hydrochloride

This classification denotes an inosine monophosphate dehydrogenase inhibitor and immunosuppressant with the molecular formula C23H31NO7.ClH, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier UXH81S8ZVB, chemically known as 4-hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-, 2-(4-morpholinyl)ethyl ester, hydrochloride, (e)- but more generally known as mycophenolate mofetil hydrochloride, which bears US NIH Compound Identifier 6441022.

UNSPSC 51203202 Mycophenolate mofetil hydrochloride is a Commodity code with no recent state and local contract opportunities directly aligned to its scope. The code designates a specific pharmaceutical ingredient used in immunosuppressive therapy, yet the recent opportunities tagged to this code cover naloxone procurement, pharmacy benefit direct-to-manufacturer contracting, emergency medical supplies, and generic multi-source pharmaceuticals and OTC products—none of which include mycophenolate mofetil or related transplant immunosuppression agents.

The mismatch between the code's nominal scope and actual recent procurement activity suggests minimal current state and local demand visibility under this Commodity code. State and local health agencies, county health departments, and cooperative purchasing organizations are actively soliciting prescription and medical supply categories, but mycophenolate mofetil does not appear in the documented recent solicitations. Firms evaluating this code should verify whether state Medicaid programs, county health systems, or specialty pharmacy networks are issuing separate procurement notices for transplant immunosuppressants outside the tagged opportunities shown here, as coding misalignment at posting time does not preclude active demand in the therapeutic category.